Predicting survival in patients with liver cancer considered for transarterial chemoembolization

S J Wigmore, D N Redhead, B N J Thomson, R W Parks, O J Garden

Research output: Contribution to journalArticlepeer-review

Abstract

Transarterial chemoembolization (TACE) has been used extensively to treat tumours confined to the liver in patients unsuitable for surgical resection. This study attempts to identify patients with liver cancer most likely to benefit from this type of treatment.
Original languageEnglish
Pages (from-to)41-5
Number of pages5
JournalEJSO - European Journal of Surgical Oncology
Volume30
Issue number1
Publication statusPublished - 2004

Fingerprint

Dive into the research topics of 'Predicting survival in patients with liver cancer considered for transarterial chemoembolization'. Together they form a unique fingerprint.

Cite this